Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fumarates | 6 | 2016 | 132 | 1.260 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 10 | 2021 | 1518 | 1.110 |
Why?
|
Amides | 6 | 2016 | 459 | 1.080 |
Why?
|
Renin | 5 | 2016 | 642 | 0.980 |
Why?
|
Angiotensin Receptor Antagonists | 7 | 2021 | 924 | 0.780 |
Why?
|
Heart Failure | 17 | 2022 | 10905 | 0.740 |
Why?
|
Enalapril | 4 | 2016 | 327 | 0.730 |
Why?
|
Rhabdomyolysis | 1 | 2020 | 150 | 0.680 |
Why?
|
Ehrlichiosis | 1 | 2018 | 29 | 0.630 |
Why?
|
Tetrazoles | 6 | 2021 | 836 | 0.600 |
Why?
|
Pancytopenia | 1 | 2018 | 104 | 0.590 |
Why?
|
Pyoderma Gangrenosum | 1 | 2017 | 76 | 0.580 |
Why?
|
Renin-Angiotensin System | 4 | 2016 | 759 | 0.570 |
Why?
|
Genital Diseases, Female | 1 | 2017 | 197 | 0.560 |
Why?
|
Acidosis | 1 | 2017 | 272 | 0.530 |
Why?
|
Antihypertensive Agents | 5 | 2023 | 2047 | 0.510 |
Why?
|
Stroke Volume | 15 | 2022 | 5008 | 0.500 |
Why?
|
Biphenyl Compounds | 6 | 2021 | 914 | 0.500 |
Why?
|
Hemofiltration | 1 | 2015 | 57 | 0.500 |
Why?
|
Carbamates | 1 | 2016 | 196 | 0.490 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2017 | 365 | 0.480 |
Why?
|
Hematinics | 3 | 2021 | 281 | 0.480 |
Why?
|
Acetaminophen | 1 | 2017 | 545 | 0.450 |
Why?
|
Diuretics | 1 | 2015 | 592 | 0.400 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 604 | 0.380 |
Why?
|
Heart Failure, Systolic | 2 | 2013 | 126 | 0.370 |
Why?
|
Ventricular Function, Left | 8 | 2022 | 3669 | 0.370 |
Why?
|
Dyspnea | 1 | 2017 | 1303 | 0.350 |
Why?
|
Neprilysin | 2 | 2019 | 439 | 0.340 |
Why?
|
Medicine | 1 | 2018 | 946 | 0.340 |
Why?
|
Hypercholesterolemia | 1 | 2015 | 1151 | 0.320 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2020 | 2103 | 0.310 |
Why?
|
Piperidines | 1 | 2016 | 1605 | 0.310 |
Why?
|
Acute Kidney Injury | 1 | 2020 | 1971 | 0.300 |
Why?
|
Venous Thromboembolism | 1 | 2020 | 1670 | 0.300 |
Why?
|
Anemia | 3 | 2021 | 1504 | 0.300 |
Why?
|
Erythropoietin | 2 | 2013 | 724 | 0.290 |
Why?
|
Cholesterol | 1 | 2015 | 2911 | 0.280 |
Why?
|
Terminal Care | 1 | 2018 | 1694 | 0.270 |
Why?
|
Anticoagulants | 2 | 2023 | 4599 | 0.270 |
Why?
|
Stroke | 3 | 2020 | 9981 | 0.270 |
Why?
|
Hospitalization | 12 | 2023 | 10262 | 0.270 |
Why?
|
Spironolactone | 2 | 2022 | 382 | 0.260 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2022 | 11732 | 0.250 |
Why?
|
Double-Blind Method | 12 | 2021 | 12035 | 0.240 |
Why?
|
Blood Glucose | 2 | 2016 | 6259 | 0.230 |
Why?
|
Cerebral Hemorrhage | 1 | 2015 | 2647 | 0.230 |
Why?
|
Mass Screening | 2 | 2016 | 5252 | 0.220 |
Why?
|
Hemorrhage | 1 | 2015 | 3461 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3132 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3239 | 0.210 |
Why?
|
Atrial Fibrillation | 2 | 2023 | 5034 | 0.200 |
Why?
|
Ramipril | 1 | 2021 | 95 | 0.200 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 916 | 0.190 |
Why?
|
Picolinic Acids | 1 | 2021 | 53 | 0.190 |
Why?
|
Carbon Monoxide | 1 | 2004 | 531 | 0.190 |
Why?
|
Natriuretic Peptides | 1 | 2022 | 150 | 0.190 |
Why?
|
Macula Lutea | 1 | 2022 | 151 | 0.190 |
Why?
|
Drug Combinations | 5 | 2021 | 1962 | 0.180 |
Why?
|
Urea Cycle Disorders, Inborn | 1 | 2020 | 31 | 0.180 |
Why?
|
Prediabetic State | 1 | 2016 | 499 | 0.180 |
Why?
|
Condylomata Acuminata | 1 | 2020 | 82 | 0.180 |
Why?
|
Pancreatitis, Chronic | 1 | 2023 | 285 | 0.180 |
Why?
|
Vasodilation | 1 | 2004 | 944 | 0.180 |
Why?
|
Forensic Medicine | 1 | 2020 | 64 | 0.180 |
Why?
|
Stress Disorders, Traumatic | 1 | 2020 | 53 | 0.180 |
Why?
|
Hyperammonemia | 1 | 2020 | 76 | 0.180 |
Why?
|
Hematologic Tests | 1 | 2020 | 240 | 0.170 |
Why?
|
Registries | 1 | 2015 | 8090 | 0.170 |
Why?
|
Humans | 45 | 2023 | 744220 | 0.170 |
Why?
|
Weight Loss | 2 | 2021 | 2622 | 0.160 |
Why?
|
Patient Discharge | 2 | 2022 | 3313 | 0.160 |
Why?
|
Creatine Kinase | 1 | 2020 | 694 | 0.160 |
Why?
|
Anaplasma phagocytophilum | 1 | 2018 | 37 | 0.160 |
Why?
|
Aged | 20 | 2021 | 163253 | 0.150 |
Why?
|
Glycine | 1 | 2021 | 671 | 0.150 |
Why?
|
Alphapapillomavirus | 1 | 2020 | 221 | 0.150 |
Why?
|
Middle Aged | 23 | 2021 | 213367 | 0.150 |
Why?
|
Endemic Diseases | 1 | 2018 | 182 | 0.150 |
Why?
|
Whipple Disease | 1 | 2016 | 19 | 0.140 |
Why?
|
Anus Neoplasms | 1 | 2020 | 332 | 0.140 |
Why?
|
Doxycycline | 1 | 2018 | 326 | 0.140 |
Why?
|
Arthralgia | 1 | 2020 | 456 | 0.140 |
Why?
|
Aftercare | 1 | 2022 | 866 | 0.140 |
Why?
|
Exanthema | 1 | 2020 | 501 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 5 | 2016 | 6535 | 0.130 |
Why?
|
Female | 26 | 2021 | 380197 | 0.130 |
Why?
|
Pyridones | 1 | 2020 | 712 | 0.130 |
Why?
|
Benzamides | 1 | 2020 | 1378 | 0.120 |
Why?
|
Rheumatic Diseases | 1 | 2021 | 593 | 0.120 |
Why?
|
Pancreatitis | 1 | 2021 | 1091 | 0.120 |
Why?
|
Insulin-Secreting Cells | 1 | 2021 | 891 | 0.120 |
Why?
|
Secondary Prevention | 1 | 2020 | 1531 | 0.120 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12961 | 0.120 |
Why?
|
Endophthalmitis | 1 | 2016 | 262 | 0.120 |
Why?
|
Male | 26 | 2021 | 350027 | 0.110 |
Why?
|
Cardiovascular Diseases | 6 | 2021 | 15161 | 0.110 |
Why?
|
Influenza Vaccines | 1 | 2021 | 738 | 0.110 |
Why?
|
Glucose Tolerance Test | 1 | 2016 | 1150 | 0.110 |
Why?
|
Fatigue | 1 | 2020 | 1531 | 0.110 |
Why?
|
Refugees | 1 | 2020 | 511 | 0.110 |
Why?
|
Hypertension | 2 | 2023 | 8480 | 0.110 |
Why?
|
Immunocompromised Host | 1 | 2017 | 847 | 0.110 |
Why?
|
Endocarditis | 1 | 2016 | 350 | 0.100 |
Why?
|
Glucose Intolerance | 1 | 2016 | 577 | 0.100 |
Why?
|
Treatment Failure | 3 | 2016 | 2619 | 0.100 |
Why?
|
Bariatric Surgery | 1 | 2021 | 952 | 0.100 |
Why?
|
Risk Assessment | 3 | 2021 | 23337 | 0.100 |
Why?
|
Inpatients | 1 | 2023 | 2518 | 0.100 |
Why?
|
Child Abuse | 1 | 2020 | 1030 | 0.100 |
Why?
|
Captopril | 1 | 2011 | 272 | 0.100 |
Why?
|
Cause of Death | 1 | 2021 | 3584 | 0.100 |
Why?
|
Renal Dialysis | 1 | 2020 | 1787 | 0.100 |
Why?
|
Glomerular Filtration Rate | 2 | 2016 | 2170 | 0.090 |
Why?
|
Obesity, Morbid | 1 | 2021 | 1213 | 0.090 |
Why?
|
Fever | 1 | 2018 | 1614 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1623 | 0.090 |
Why?
|
Pyrazoles | 1 | 2020 | 1973 | 0.090 |
Why?
|
Acute Disease | 2 | 2023 | 7148 | 0.090 |
Why?
|
Influenza, Human | 1 | 2021 | 1480 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2864 | 0.090 |
Why?
|
Creatinine | 1 | 2015 | 1919 | 0.090 |
Why?
|
Single-Blind Method | 2 | 2019 | 1590 | 0.080 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2011 | 453 | 0.080 |
Why?
|
Medication Adherence | 1 | 2020 | 2062 | 0.080 |
Why?
|
Papillomavirus Infections | 1 | 2020 | 1587 | 0.080 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6172 | 0.080 |
Why?
|
Aspirin | 1 | 2020 | 3282 | 0.080 |
Why?
|
Risk Factors | 6 | 2023 | 72280 | 0.080 |
Why?
|
Pyridines | 1 | 2020 | 2822 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2021 | 2072 | 0.080 |
Why?
|
Myocardial Infarction | 3 | 2021 | 11728 | 0.080 |
Why?
|
Insulin Resistance | 1 | 2021 | 3863 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2020 | 3068 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2021 | 5316 | 0.070 |
Why?
|
Diabetes Mellitus | 1 | 2016 | 5755 | 0.070 |
Why?
|
Blood Pressure | 3 | 2023 | 8551 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2208 | 0.070 |
Why?
|
Proportional Hazards Models | 4 | 2021 | 12355 | 0.070 |
Why?
|
Drug Therapy, Combination | 3 | 2016 | 6485 | 0.070 |
Why?
|
Hemoglobins | 2 | 2021 | 1533 | 0.070 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13990 | 0.070 |
Why?
|
Thromboembolism | 2 | 2021 | 985 | 0.070 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8628 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3256 | 0.060 |
Why?
|
Massachusetts | 1 | 2018 | 8663 | 0.060 |
Why?
|
Adult | 8 | 2023 | 214035 | 0.060 |
Why?
|
Pediatrics | 1 | 2020 | 3469 | 0.060 |
Why?
|
Prospective Studies | 5 | 2021 | 53280 | 0.060 |
Why?
|
Tetraethylammonium | 1 | 2004 | 58 | 0.060 |
Why?
|
Nitroarginine | 1 | 2004 | 66 | 0.060 |
Why?
|
Physicians | 1 | 2023 | 4564 | 0.060 |
Why?
|
Hypotension | 2 | 2021 | 880 | 0.060 |
Why?
|
Oxadiazoles | 1 | 2004 | 93 | 0.060 |
Why?
|
Nitric Oxide Donors | 1 | 2004 | 121 | 0.060 |
Why?
|
Nitroprusside | 1 | 2004 | 275 | 0.060 |
Why?
|
Pia Mater | 1 | 2004 | 88 | 0.060 |
Why?
|
Young Adult | 3 | 2020 | 56436 | 0.060 |
Why?
|
Body Weight | 1 | 2015 | 4666 | 0.060 |
Why?
|
Potassium Channel Blockers | 1 | 2004 | 171 | 0.060 |
Why?
|
Primary Health Care | 1 | 2020 | 4556 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 12718 | 0.060 |
Why?
|
Arterioles | 1 | 2004 | 254 | 0.060 |
Why?
|
Cyclic GMP | 1 | 2004 | 409 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7281 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2015 | 9960 | 0.050 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 7179 | 0.050 |
Why?
|
Treatment Outcome | 6 | 2021 | 63119 | 0.050 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39045 | 0.050 |
Why?
|
Quinoxalines | 1 | 2004 | 290 | 0.050 |
Why?
|
Death, Sudden, Cardiac | 1 | 2010 | 1541 | 0.050 |
Why?
|
Cerebral Arteries | 1 | 2004 | 494 | 0.050 |
Why?
|
Prognosis | 1 | 2022 | 29050 | 0.050 |
Why?
|
Kidney | 2 | 2020 | 7183 | 0.050 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2004 | 689 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9275 | 0.050 |
Why?
|
Vaccines, Inactivated | 1 | 2021 | 184 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2021 | 424 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8387 | 0.040 |
Why?
|
Ammonia | 1 | 2020 | 239 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2017 | 57768 | 0.040 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2021 | 172 | 0.040 |
Why?
|
Lipase | 1 | 2021 | 315 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2021 | 426 | 0.040 |
Why?
|
Cohort Studies | 2 | 2020 | 40559 | 0.040 |
Why?
|
Length of Stay | 2 | 2023 | 6308 | 0.040 |
Why?
|
Glucosides | 1 | 2022 | 451 | 0.040 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2023 | 789 | 0.040 |
Why?
|
Ferritins | 1 | 2021 | 590 | 0.040 |
Why?
|
American Heart Association | 1 | 2023 | 1056 | 0.040 |
Why?
|
Hospitals | 2 | 2023 | 3952 | 0.040 |
Why?
|
Urea | 1 | 2020 | 451 | 0.040 |
Why?
|
Angioedema | 1 | 2019 | 187 | 0.040 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2004 | 1504 | 0.040 |
Why?
|
Fluorescein Angiography | 1 | 2022 | 940 | 0.040 |
Why?
|
Survival Analysis | 2 | 2021 | 10250 | 0.040 |
Why?
|
Research Design | 3 | 2011 | 5987 | 0.040 |
Why?
|
Orchitis | 1 | 2016 | 35 | 0.040 |
Why?
|
Epididymitis | 1 | 2016 | 37 | 0.040 |
Why?
|
Retinal Vessels | 1 | 2022 | 772 | 0.040 |
Why?
|
Medical History Taking | 1 | 2020 | 783 | 0.030 |
Why?
|
Benzhydryl Compounds | 1 | 2022 | 845 | 0.030 |
Why?
|
Shock, Septic | 1 | 2013 | 775 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2023 | 77426 | 0.030 |
Why?
|
Sex Distribution | 1 | 2021 | 2297 | 0.030 |
Why?
|
Ceftriaxone | 1 | 2016 | 168 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2004 | 2131 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2016 | 6893 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2903 | 0.030 |
Why?
|
Patient Readmission | 2 | 2023 | 3114 | 0.030 |
Why?
|
Papillomaviridae | 1 | 2020 | 1119 | 0.030 |
Why?
|
Swine | 1 | 2004 | 5940 | 0.030 |
Why?
|
HIV Infections | 1 | 2020 | 16718 | 0.030 |
Why?
|
Physical Examination | 1 | 2020 | 1238 | 0.030 |
Why?
|
Myositis | 1 | 2016 | 251 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3270 | 0.030 |
Why?
|
Brain | 1 | 2020 | 26413 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 3913 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3800 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35423 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3527 | 0.030 |
Why?
|
Resilience, Psychological | 1 | 2020 | 675 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2020 | 1240 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2011 | 1573 | 0.030 |
Why?
|
Adolescent | 2 | 2020 | 85759 | 0.030 |
Why?
|
Endothelium, Vascular | 1 | 2004 | 4455 | 0.030 |
Why?
|
Heart Rate | 1 | 2023 | 4092 | 0.030 |
Why?
|
Patient Care Team | 1 | 2023 | 2529 | 0.030 |
Why?
|
Time Factors | 3 | 2016 | 40063 | 0.020 |
Why?
|
Comorbidity | 1 | 2016 | 10387 | 0.020 |
Why?
|
Arthritis | 1 | 2016 | 659 | 0.020 |
Why?
|
Chronic Disease | 1 | 2016 | 9147 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2020 | 6037 | 0.020 |
Why?
|
Sodium Chloride, Dietary | 1 | 2011 | 281 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2022 | 2657 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3778 | 0.020 |
Why?
|
Prevalence | 1 | 2016 | 15226 | 0.020 |
Why?
|
Seizures | 1 | 2020 | 2859 | 0.020 |
Why?
|
United States | 3 | 2023 | 69867 | 0.020 |
Why?
|
Aldosterone | 1 | 2011 | 877 | 0.020 |
Why?
|
Placebos | 1 | 2010 | 1677 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10396 | 0.020 |
Why?
|
Syndrome | 1 | 2010 | 3250 | 0.020 |
Why?
|
Disease Progression | 1 | 2011 | 13280 | 0.010 |
Why?
|
Europe | 1 | 2010 | 3339 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2021 | 15538 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21752 | 0.010 |
Why?
|
Outpatients | 1 | 2010 | 1486 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25043 | 0.010 |
Why?
|
Hemodynamics | 1 | 2010 | 4199 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10949 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 12805 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 40992 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12244 | 0.010 |
Why?
|
Incidence | 1 | 2014 | 20945 | 0.010 |
Why?
|
Animals | 1 | 2004 | 168788 | 0.010 |
Why?
|
Child | 1 | 2020 | 77679 | 0.010 |
Why?
|
Concepts
(257)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(52)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_